Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Protease-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
1 |
amylase + lipase + protease 16600 enheder/5000 enheder/18750 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 20000 enheder/4500 enheder/25000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase 20000 enheder + lipase 5000 enheder + protease 20000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 25000 enheder/4000 enheder/25000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 30000 enheder/10000 enheder/30000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 30000 enheder/8000 enheder/30000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 30000 enheder/8000 enheder/30000 enheder tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 3000 enheder/2400 enheder/3000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 33200 enheder/10000 enheder/37500 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 39000 enheder/12000 enheder/39000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 40000 enheder/8000 enheder/45000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 48000 enheder/16000 enheder/48000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 56000 enheder/20000 enheder/44000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
Amylase + lipase + protease 58500unt/18000unt/58500unt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 58500 enheder/18000 enheder/58500 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 6000 enheder/16000 enheder/6000 enheder tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 65000 enheder/20000 enheder/65000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 66400 enheder/20000 enheder/75000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 664400 enheder/20000 enheder/75000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 8000 enheder/30000 enheder/30000 enheder tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease 12000 enheder/4000 enheder/12000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + pancreaslipase + pancreasprotease, kapsel à 65000 enheder/20000 enheder/65000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
amylase + lipase + protease |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
2 |
Product containing human protease inhibitor protein (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
A substance containing enzymes, mainly lipase, with amylase and protease, obtained from the pancreas of the hog. It is a cream-coloured, amorphous powder having a faint characteristic, but not offensive odour. Its greatest activities are in neutral or faintly alkaline media; more than traces of mineral acids or large amounts of alkali hydroxides make it inert. An excess of alkali carbonate also inhibits its action. Pancrelipase contains, in each mg, not less than 24 USP units of lipase activity, not less than 100 USP units of amylase activity, and not less than 100 USP units of protease activity. |
Is a |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
Ocriplasmin |
Is a |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
Bromelains (substance) |
Is a |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
Pepsin powder |
Is a |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
Product containing only amylase and substance with protease mechanism of action and triacylglycerol lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
2 |
Tissue plasminogen activator |
Is a |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|
Substance with plasminogen activator mechanism of action (substance) |
Is a |
False |
Substance with protease mechanism of action |
Inferred relationship |
Some |
|